Crossref journal-article
Springer Science and Business Media LLC
Nature (297)
Bibliography

Pellegrini, L., Burke, D. F., von Delft, F., Mulloy, B., & Blundell, T. L. (2000). Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin. Nature, 407(6807), 1029–1034.

Authors 5
  1. Luca Pellegrini (first)
  2. David F. Burke (additional)
  3. Frank von Delft (additional)
  4. Barbara Mulloy (additional)
  5. Tom L. Blundell (additional)
References 30 Referenced 597
  1. Galzie, Z., Kinsella, A. R. & Smith, J. A. Fibroblast growth factors and their receptors. Biochem. Cell. Biol. 75, 669–685 (1997). (10.1139/o97-091) / Biochem. Cell. Biol. by Z Galzie (1997)
  2. Johnson, D. E. & Williams, L. T. Structural and functional diversity in the FGF receptor multigene family. Adv. Cancer Res. 60, 1–41 (1993). / Adv. Cancer Res. by DE Johnson (1993)
  3. Rapraeger, A. C., Krufka, A. & Olwin, B. B. Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science 252, 1705–1708 (1991). (10.1126/science.1646484) / Science by AC Rapraeger (1991)
  4. Spivak-Kroizman, T. et al. Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation and cell proliferation. Cell 79, 1015–1024 ( 1994). (10.1016/0092-8674(94)90032-9) / Cell by T Spivak-Kroizman (1994)
  5. Lin, X., Buff, E. M., Perrimon, N. & Michelson, A. M. Heparan sulfate proteoglycans are essential for FGF receptor signaling during Drosophila embryonic development. Development 126 , 3715–3723 (1999). (10.1242/dev.126.17.3715) / Development by X Lin (1999)
  6. Faham, S., Hileman, R. E., Fromm, J. R., Linhardt, R. J. & Rees, D. C. Heparin structure and interactions with basic fibroblast growth factor. Science 271, 1116–1120 (1996). (10.1126/science.271.5252.1116) / Science by S Faham (1996)
  7. DiGabriele, A. et al. Structure of a heparin-linked biologically active dimer of fibroblast growth factor. Nature 393, 812 –817 (1998). (10.1038/31741) / Nature by A DiGabriele (1998)
  8. Plotnikov, A. N., Schlessinger, J., Hubbard, S. R. & Mohammadi, M. Structural basis for FGF receptor dimerization and activation. Cell 98, 641–650 ( 1999). (10.1016/S0092-8674(00)80051-3) / Cell by AN Plotnikov (1999)
  9. Stauber, D., DiGabriele, A. & Hendrickson, W. Structural Interactions of fibroblast growth factor receptor with its ligands. Proc. Natl Acad. Sci. USA 97, 49–54 (2000). (10.1073/pnas.97.1.49) / Proc. Natl Acad. Sci. USA by D Stauber (2000)
  10. Zhu, X. et al. Three-dimensional structure of acidic and basic fibroblast growth factor. Science 251, 90– 93 (1991). (10.1126/science.1702556) / Science by X Zhu (1991)
  11. Thompson, L. D., Pantoliano, M. W. & Springer, B. A. Energetic characterization of the basic fibroblast growth factor-heparin interaction: identification of the heparin binding domain. Biochemistry 33, 3831– 3840 (1994). (10.1021/bi00179a006) / Biochemistry by LD Thompson (1994)
  12. Springer, B. A. et al. Identification and concerted function of two receptor binding surfaces on basic fibroblast growth factor required for mitogenesis. J. Biol. Chem. 269, 26879–26884 (1994). (10.1016/S0021-9258(18)47101-3) / J. Biol. Chem. by BA Springer (1994)
  13. Kan, M. et al. An essential heparin-binding domain in the fibroblast growth factor receptor kinase. Science 259, 1918– 1921 (1993). (10.1126/science.8456318) / Science by M Kan (1993)
  14. Guimond, S., Maccarana, M., Olwin, B. B., Lindahl, U. & Rapraeger, A. C. Activating and inhibitory heparin sequences for FGF-2 (basic FGF). Distinct requirements for FGF-1, FGF-2, and FGF-4. J. Biol. Chem. 268, 23906– 23914 (1993). (10.1016/S0021-9258(20)80471-2) / J. Biol. Chem. by S Guimond (1993)
  15. Ornitz, D. M. et al. Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells. Mol. Cell. Biol. 12, 240–247 (1992). (10.1128/MCB.12.1.240) / Mol. Cell. Biol. by DM Ornitz (1992)
  16. Sudhalter, J., Folkman, J., Svahn, C. M., Bergendal, K. & D'Amore, P. A. Importance of size, sulfation, and anticoagulant activity in the potentiation of acidic fibroblast growth factor by heparin. J. Biol. Chem. 264, 6892 –6897 (1989). (10.1016/S0021-9258(18)83515-3) / J. Biol. Chem. by J Sudhalter (1989)
  17. Wang, F., Kan, M., Xu, J., Yan, G. & McKeehan, W. L. Ligand-specific structural domains in the fibrobast growth factor receptor. J. Biol. Chem. 270, 10222–10230 (1995). (10.1074/jbc.270.17.10222) / J. Biol. Chem. by F Wang (1995)
  18. Zhu, H. et al. Analysis of high-affinity binding determinants in the receptor binding epitope of basic fibroblast growth factor. Protein Eng. 10, 417–421 (1997). (10.1093/protein/10.4.417) / Protein Eng. by H Zhu (1997)
  19. Zhu, H. et al. Glu-96 of basic fibroblast growth factor is essential for high affinity receptor binding. Identification by structure-based site-directed mutagenesis. J. Biol. Chem. 270, 21869– 21874 (1995). (10.1074/jbc.270.37.21869) / J. Biol. Chem. by H Zhu (1995)
  20. Plopper, G. E., McNamee, H. P., Dike, L. E., Bojanowski, K. & Ingber, D. E. Convergence of integrin and growth factor receptor signaling pathways within the focal adhesion complex. Mol. Biol. Cell 6, 1349–1365 (1995). (10.1091/mbc.6.10.1349) / Mol. Biol. Cell by GE Plopper (1995)
  21. Oldridge, M. et al. Genotype-phenotype correlation for nucleotide substitutions in the IgII–IgIII linker of FGFR2. Hum. Mol. Genet. 6, 137–143 (1997). (10.1093/hmg/6.1.137) / Hum. Mol. Genet. by M Oldridge (1997)
  22. Reimer, U. et al. Side-chain effects on peptidyl-prolyl cis/trans isomerisation. J. Mol. Biol. 279, 449– 460 (1998). (10.1006/jmbi.1998.1770) / J. Mol. Biol. by U Reimer (1998)
  23. Rice, K. G., Kim, Y. S., Grant, A. C., Merchant, Z. M. & Linhardt, R. J. High-performance liquid chromatographic separation of heparin-derived oligosaccharides. Anal. Biochem. 150, 325–331 (1985). (10.1016/0003-2697(85)90518-4) / Anal. Biochem. by KG Rice (1985)
  24. Otwinowski, Z. & Minor, W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307–326 ( 1997). (10.1016/S0076-6879(97)76066-X) / Methods Enzymol. by Z Otwinowski (1997)
  25. Sheldrick, G. M. & Schneider, T. R. SHELXL: high resolution refinement. Methods Enzymol. 277, 319–343 (1997). (10.1016/S0076-6879(97)77018-6) / Methods Enzymol. by GM Sheldrick (1997)
  26. La Fortelle, E. d. & Bricogne, G. Maximum-likelihood heavy-atom parameter refinement in the MIR and MAD methods. Methods Enzymol. 276, 472–494 ( 1997). (10.1016/S0076-6879(97)76073-7) / Methods Enzymol. by Ed La Fortelle (1997)
  27. Abrahams, J. P. & Leslie, A. G. W. Methods used in the structure determination of bovine mitochondrial F1 ATPase. Acta Crystallogr. D 52, 30–42 (1996). (10.1107/S0907444995008754) / Acta Crystallogr. D by JP Abrahams (1996)
  28. Mulloy, B., Forster, M. J., Jones, C. & Davies, D. B. N.m.r. and molecular-modelling studies of the solution conformation of heparin. Biochem. J. 293, 849–858 (1993). (10.1042/bj2930849) / Biochem. J. by B Mulloy (1993)
  29. Brunger, A. T. et al. Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr. D 54, 905–921 (1998). (10.1107/S0907444998003254) / Acta Crystallogr. D by AT Brunger (1998)
  30. Jones, T. A., Zou, J. Y., Cowan, S. W. & Kjeldgaard, M. Improved methods for binding protein models in electron-density maps and the location of errors in these models. Acta Crystallogr. A 47, 110–119 (1991). (10.1107/S0108767390010224) / Acta Crystallogr. A by TA Jones (1991)
Dates
Type When
Created 23 years, 1 month ago (July 26, 2002, 4:46 a.m.)
Deposited 2 years, 3 months ago (May 16, 2023, 10:12 p.m.)
Indexed 1 week, 3 days ago (Aug. 26, 2025, 2:47 a.m.)
Issued 24 years, 11 months ago (Oct. 1, 2000)
Published 24 years, 11 months ago (Oct. 1, 2000)
Published Print 24 years, 11 months ago (Oct. 1, 2000)
Funders 0

None

@article{Pellegrini_2000, title={Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin}, volume={407}, ISSN={1476-4687}, url={http://dx.doi.org/10.1038/35039551}, DOI={10.1038/35039551}, number={6807}, journal={Nature}, publisher={Springer Science and Business Media LLC}, author={Pellegrini, Luca and Burke, David F. and von Delft, Frank and Mulloy, Barbara and Blundell, Tom L.}, year={2000}, month=oct, pages={1029–1034} }